Slides: Potential mechanisms of benefit of icosapent ethyl
Slides as educational service to PACE members.
This lecture by prof. Chris Packard, PhD is part of an educational series entitled "CV risk reduction beyond statin therapy: Exploring the role of Icosapent ethyl".
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: